Relypsa Inc (RLYP)

Sector:
HEALTH CARE
Industry:
HEALTH CARE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
John A. Orwin
Employees:
429
100 CARDINAL WAY, REDWOOD CITY, CA 94063
650-421-9500

• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Relypsa, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of polymeric medicines for patients with conditions that are overlooked and undertreated and can be addressed in the gastrointestinal tract pr...

Data derived from most recent annual or quarterly report
Market Cap 1.432 Billion Shares Outstanding44.75 Million Avg 30-day Volume 1.884 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-1.87
Price to Revenue22.9671 Debt to Equity1.4297 EBITDA-227.133 Million
Price to Book Value7.4858 Operating Margin-636.4119 Enterprise Value731.183 Million
Current Ratio6.997 EPS Growth-0.862 Quick Ratio6.096
1 Yr BETA 1.4189 52-week High/Low 0.0 / Profit Margin-686.4382
Operating Cash Flow Growth-150.1696 Free Cash Flow to Firm (FCFF) TTM -181.553 Million Free Cash Flow to Equity (FCFE) TTM1.6 Thousand
Altman Z-Score-1.6406
View SEC Filings from RLYP instead.

View recent insider trading info

Relypsa Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding RLYP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RLYP

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2016-09-02 by RELYPSA INC
  • 4: filed on 2016-09-02 by RELYPSA INC
  • 4: filed on 2016-09-02 by RELYPSA INC
  • 4: filed on 2016-09-02 by RELYPSA INC
  • 4: filed on 2016-09-02 by RELYPSA INC
  • 4: filed on 2016-09-02 by RELYPSA INC
  • 4: filed on 2016-09-02 by RELYPSA INC
  • 4: filed on 2016-09-02 by RELYPSA INC
  • 4: filed on 2016-09-02 by RELYPSA INC
  • 4: filed on 2016-09-02 by RELYPSA INC

    • Events (8k)

  • 8-K: filed on 2016-09-01:
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-07-21:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-07-11:
    Item 8.01: Other Events
  • 8-K: filed on 2016-06-27:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2016-06-15:
    Item 8.01: Other Events
  • 8-K: filed on 2016-05-16:
    Item 8.01: Other Events
  • 8-K: filed on 2016-05-04:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-05-03:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2016-04-15:
    Item 8.01: Other Events
  • 8-K: filed on 2016-03-15:
    Item 8.01: Other Events

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    MCGIRR DAVID W J

    • Director
    		 No longer subject to file 2016-09-01 0

    SPIEGELMAN DANIEL K

    • Director
    		 No longer subject to file 2016-09-01 0

    BALL KRISTINE M CHIEF FINANCIAL OFFICER & SVP

    • Officer
    		 No longer subject to file 2016-09-01 0

    HASTINGS PAUL J

    • Director
    		 No longer subject to file 2016-09-01 0

    BERMAN LANCE CHIEF MEDICAL OFFICER AND SVP

    • Officer
    		 No longer subject to file 2016-09-01 0

    ORWIN JOHN A PRESIDENT & CEO

    • Officer
    • Director
    		 No longer subject to file 2016-09-01 0

    TORLEY HELEN

    • Director
    		 No longer subject to file 2016-09-01 0

    GARLAND J. SCOTT SVP & CHIEF COMMERCIAL OFFICER

    • Officer
    		 No longer subject to file 2016-09-01 0

    SCHUETZ THOMAS J.

    • Director
    		 No longer subject to file 2016-09-01 0

    BUTLER JOHN P.

    • Director
    		 No longer subject to file 2016-09-01 0

    STAHL WILHELM SVP, CHIEF TECHNOLOGY OFFICER

    • Officer
    		 No longer subject to file 2016-09-01 0

    KRASNOW RONALD A. SEE REMARKS

    • Officer
    		 No longer subject to file 2016-09-01 0

    CORBETT MARY SENIOR VP, HUMAN RESOURCES

    • Officer
    		 No longer subject to file 2016-09-01 0

    HILLAN KENNETH J.

    • Director
    		 No longer subject to file 2016-09-01 0

    HARRISON STEPHEN D SVP & CHIEF SCIENTIFIC OFFICER

    • Officer
    		 No longer subject to file 2016-09-01 0

    MONTGOMERY MONTE CHIEF ACCOUNTING OFFICER

    • Officer
    		 No longer subject to file 2016-09-01 0

    DONDERO JAMES D

    • 10% Owner
    		 128,500 2016-08-17 0

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP IV LLC

    ISALY SAMUEL D

    • 10% Owner
    		 No longer subject to file 2016-07-22 0

    LOCKEY CLAIRE SEE REMARKS

    • Officer
    		 10,478 2015-08-17 0

    VEITINGER KLAUS R DR

    • Director
    		 2,712 2015-05-11 0

    5AM PARTNERS III, LLC

    5AM VENTURES III, L.P.

    5AM CO-INVESTORS III, L.P.

    • 10% Owner
    		 No longer subject to file 2014-12-09 0

    5AM PARTNERS II, LLC

    5AM VENTURES II LP

    5AM CO-INVESTORS II LP

    • 10% Owner
    		 1,319,480 2014-09-16 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments